Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights.

Bill: 117-hres-1285
Sponsor: full_name: Rep. Smith, Adrian [R-NE-3]
Introduced: 2022-07-26
Policy area: Foreign Trade and International Finance
Subjects: Asia

Cardiovascular and respiratory health

China

Congressional oversight

Congressional-executive branch relations

Emergency medical services and trauma care

Free trade and trade barriers

Government information and archives

Health technology, devices, supplies

Immunology and vaccination

Infectious and parasitic diseases

Intellectual property

Presidents and presidential powers, Vice Presidents

Trade agreements and negotiations

World health
Latest action: action_date: 2022-09-28
text: Placed on the House Calendar, Calendar No. 127.

Summaries:
action_date: 2022-07-26
action_desc: Introduced in House
text: <p>This resolution requests that the President transmit certain information to the House of Representatives related to the June 17, 2022, waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (known as the TRIPS waiver) and the proposed expansion of the TRIPS waiver. </p> <p>In particular, the resolution requests information demonstrating that</p> <ul> <li>the TRIPS waiver will increase global supply and delivery of COVID-19 vaccines and the extent to which these vaccines have been destroyed due to their expiration;</li> <li>the proposed TRIPS waiver expansion will increase global supply and delivery of COVID-19 diagnostics or therapeutics;</li> <li>the TRIPS waiver or the proposed TRIPS waiver expansion will accelerate the end of the COVID-19 pandemic; and</li> <li>China will not obtain access to patents or other intellectual property related to COVID-19 vaccines, diagnostics, or therapeutics even if expressly excluded from the TRIPS waiver or the proposed TRIPS waiver expansion.</li> </ul>

action_date: 2022-09-28
action_desc: Reported to House
text: <p>This resolution requests that the President transmit certain information to the House of Representatives related to the June 17, 2022, waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (known as the TRIPS waiver) and the proposed expansion of the TRIPS waiver. </p> <p>In particular, the resolution requests information demonstrating that</p> <ul> <li>the TRIPS waiver will increase global supply and delivery of COVID-19 vaccines and the extent to which these vaccines have been destroyed due to their expiration;</li> <li>the proposed TRIPS waiver expansion will increase global supply and delivery of COVID-19 diagnostics or therapeutics;</li> <li>the TRIPS waiver or the proposed TRIPS waiver expansion will accelerate the end of the COVID-19 pandemic; and</li> <li>China will not obtain access to patents or other intellectual property related to COVID-19 vaccines, diagnostics, or therapeutics even if expressly excluded from the TRIPS waiver or the proposed TRIPS waiver expansion. </li></ul>

tv_txt: IV 117th CONGRESS 2d Session H. RES. 1285 IN THE HOUSE OF REPRESENTATIVES July 26, 2022 Mr. Smith of Nebraska (for himself and Mr. Brady ) submitted the following resolution; which was referred to the Committee on Ways and Means RESOLUTION Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights.

That the President is requested to transmit to the House of Representatives, not later than 14 days after the date of the adoption of this resolution, copies of all documents, memoranda, advisory legal opinions, notes from meetings, audio recordings, records (including telephone and electronic mail records), correspondence, or other communications, or any portion of any such communications, to the extent that any such one or more items are within the possession of the President, that demonstrate— (1) the waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (in this resolution referred to as TRIPS waiver ) that was agreed to on June 17, 2022, will increase global supply and delivery of COVID–19 vaccines; (2) the extent to which COVID–19 vaccines have been destroyed due to their expiration and the period during which this occurred; (3) the proposed expansion of the TRIPS waiver to cover intellectual property related to diagnostics and therapeutics (in this resolution referred to as the proposed TRIPS waiver expansion ) will increase global supply and delivery of COVID–19 diagnostics or therapeutics; (4) the TRIPS waiver or the proposed TRIPS waiver expansion will accelerate the end of the COVID–19 pandemic; and (5) the People’s Republic of China will not obtain access to patents or other intellectual property related to COVID–19 vaccines, diagnostics, or therapeutics, even if China is expressly excluded from the TRIPS waiver or the proposed TRIPS waiver expansion.

tv_txt: IV House Calendar No. 127 117th CONGRESS 2d Session H. RES. 1285 [Report No. 117–520] IN THE HOUSE OF REPRESENTATIVES July 26, 2022 Mr. Smith of Nebraska (for himself and Mr. Brady ) submitted the following resolution; which was referred to the Committee on Ways and Means September 28, 2022 Reported adversely from the Committee on Ways and Means , referred to the House Calendar, and ordered to be printed RESOLUTION Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights.

That the President is requested to transmit to the House of Representatives, not later than 14 days after the date of the adoption of this resolution, copies of all documents, memoranda, advisory legal opinions, notes from meetings, audio recordings, records (including telephone and electronic mail records), correspondence, or other communications, or any portion of any such communications, to the extent that any such one or more items are within the possession of the President, that demonstrate— (1) the waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (in this resolution referred to as TRIPS waiver ) that was agreed to on June 17, 2022, will increase global supply and delivery of COVID–19 vaccines; (2) the extent to which COVID–19 vaccines have been destroyed due to their expiration and the period during which this occurred; (3) the proposed expansion of the TRIPS waiver to cover intellectual property related to diagnostics and therapeutics (in this resolution referred to as the proposed TRIPS waiver expansion ) will increase global supply and delivery of COVID–19 diagnostics or therapeutics; (4) the TRIPS waiver or the proposed TRIPS waiver expansion will accelerate the end of the COVID–19 pandemic; and (5) the People’s Republic of China will not obtain access to patents or other intellectual property related to COVID–19 vaccines, diagnostics, or therapeutics, even if China is expressly excluded from the TRIPS waiver or the proposed TRIPS waiver expansion.

September 28, 2022 Reported adversely from the Committee on Ways and Means , referred to the House Calendar, and ordered to be printed